Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis have?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis has 850 citations in the OpenAlex counts ScholarIQ stores.
When was Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis published?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis has 2024 year in the ScholarIQ index.
What is the open-access status of Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis?
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis has closed oa status in the ScholarIQ index.
What is the DOI of Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis?
The DOI for Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis is on the source record.
What is the PMID of Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis?
The PMID for Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis is on the source record.
What is the OpenAlex record for Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis?
The OpenAlex for Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis is on the source record.